Health Effects of Extreme Heat, Wildfire Smoke Worse When Combined
(MedPage Today) -- Extreme heat and wildfire smoke are independently harmful to the human body, but together their impact on cardiovascular and respiratory systems is more dangerous and affects some communities more than others.
A study published... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 2, 2024 Category: Allergy & Immunology Source Type: news
Clinical Challenges: Test Your Knowledge of Food Allergies
(MedPage Today) -- A three-question quiz covering our series on different aspects of food allergy management (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 31, 2024 Category: Allergy & Immunology Source Type: news
Clinical Challenges: Anaphylaxis and Epinephrine
(MedPage Today) -- Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and 150 deaths each year.
While... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 31, 2024 Category: Allergy & Immunology Source Type: news
Are Your Patients Prepared to Switch Their Asthma Inhaler?
(MedPage Today) -- If you have not heard already, one of the most popular inhalers has been discontinued by its manufacturer since January 1. GlaxoSmithKline (GSK) has stopped producing Flovent, which comes as a metered-dose inhaler (Flovent HFA... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 12, 2024 Category: Allergy & Immunology Source Type: news
Clinical Challenges: Oral Immunotherapy for Food Allergies
(MedPage Today) -- Hailed for opening a new chapter in food allergy management, oral immunotherapy (OIT) is nevertheless going through growing pains in accessibility and acceptance in clinical practice.
In 2020, the FDA approved peanut allergen... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 10, 2024 Category: Allergy & Immunology Source Type: news
FDA Rejects Drug for Chronic Cough
(MedPage Today) -- The FDA declined to approve oral gefapixant for treating chronic cough, Merck announced on Wednesday.
In its complete response letter, "the FDA concluded that Merck's application did not meet substantial evidence of effectiveness... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - December 21, 2023 Category: Allergy & Immunology Source Type: news
Asthma Attacks Decreased Among Black Patients During the Pandemic
(MedPage Today) -- Despite Black patients having the highest prevalence of asthma prior to the COVID-19 pandemic, decreasing trends in asthma attacks were observed for this population during the pandemic relative to white patients, according to... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - December 18, 2023 Category: Allergy & Immunology Source Type: news
Epinephrine Was First an Asthma Treatment
(MedPage Today) -- This is the first in an occasional series on the origin of commonly used medicines.
When epinephrine was first discovered at the turn of the 20th century, it was essentially a drug without a disease.
In 1894, two British researchers... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 24, 2023 Category: Allergy & Immunology Source Type: news
Drug Candidate for Chronic Cough Rejected by FDA Panel
(MedPage Today) -- FDA advisors told the agency that the current evidence does not support approval of gefapixant for chronic cough, a condition where no approved therapy exists.
On Friday, members of the Pulmonary-Allergy Drugs Advisory Committee... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 18, 2023 Category: Allergy & Immunology Source Type: news
Here's Why People Think They Developed Food Allergies
(MedPage Today) -- ANAHEIM, Calif. -- Patients and their caregivers believe that a wide array of causes are responsible for the development of their food allergies, according to findings from a national cross-sectional survey.
The factors that... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 17, 2023 Category: Allergy & Immunology Source Type: news
Unclear if Chronic Cough Drug Has Meaningful Benefit, FDA Reviewers Say
(MedPage Today) -- It remains "unclear" whether the modest effects of gefapixant, an investigational drug for chronic cough, represent a clinically meaningful benefit, said FDA staff ahead of a meeting of the agency's Pulmonary-Allergy Drugs Advisory... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 16, 2023 Category: Allergy & Immunology Source Type: news
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trials
(MedPage Today) -- ANAHEIM, Calif. -- Treatment with remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, led to fast improvement in symptom control for patients with chronic spontaneous urticaria (CSU) inadequately controlled... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 15, 2023 Category: Allergy & Immunology Source Type: news
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trial
(MedPage Today) -- ANAHEIM, Calif. -- Treatment with remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, led to fast improvement in symptom control for patients with chronic spontaneous urticaria (CSU) inadequately controlled... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 14, 2023 Category: Allergy & Immunology Source Type: news
Asthma-Tracking App Shows Some Promise for Reducing ED Visits
(MedPage Today) -- ANAHEIM, Calif. -- A comprehensive, smartphone app-based program failed to reduce healthcare utilization among asthma patients with private insurance, but did benefit those on Medicaid, a large randomized controlled trial found... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 14, 2023 Category: Allergy & Immunology Source Type: news
AI Gets It Mostly Right on Allergy Myths
(MedPage Today) -- ANAHEIM, Calif. -- ChatGPT did a fairly good job at sifting through notable allergy myths, but the AI software sometimes gave conflicting answers and allergists themselves failed to agree on how accurate its verdicts were... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 14, 2023 Category: Allergy & Immunology Source Type: news
